ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 48

Tissue Engineering for Articular Cartilage Repair, Culturing Bone Marrow Mesenchymal Stem Cells On Collagen and Heparan Sulphate Scaffolds

Adela Helvia Martinez-Sanchez1, Clara Sanjurjo-Rodriguez1, Silvia Diaz-Prado2, Emma Muiños1, Isaac M. Fuentes2, Francisco J. De Toro2, Julia Bujan3 and Francisco J. Blanco1, 1Osteoarticular and Aging Res. Lab. CIBER-BBN. Rheumatology Div. INIBIC-Complejo Hosp. Univ. A Coruña, A Coruña, Spain, 2Osteoarticular and Aging Res. Lab. CIBER-BBN. INIBIC-University of A Coruña, A Coruña, Spain, 3Department of Medical Specialties. University of Alcala de Henares, Madrid, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cartilage, Collagen, extracellular matrix proteins, Mesenchymal stem cells and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

 

Background/Purpose: The aim of this study was to evaluate the chondrogenic potential of bone marrow mesenchymal stem cells (BM-MSCs) grown on type I collagen and different concentrations of heparan sulfate (HS) scaffolds and the quality of the neosynthesized cartilaginous tissue.

Methods: BM-MSCs were cultured on scaffolds for 16 and 30 days. BM-MSCs were cultured in chondrogenic differentiation medium or DMEM with 20% FBS (Fetal Bovine Serum), in both cases plus 100 nM PTHrP (Parathyroid hormone-related protein). Chondrogenic differentiation and neosythesized cartilage quality were evaluated by histochemical and immunohistochemical analysis, transmission and scanning electron microscopy and molecular biology techniques. Culture supernatants were collected every 3-4 days to determine collagen presence by Elisa assays.

Results: Isolated cells were able to proliferate on type I collagen and various concentrations of HS scaffolds, showing high percentages of positivity for PCNA proliferation marker. Hematoxylin-eosin and Massonxs trichrome stainings showed that BM-MSCs proliferated better when cultured in chondrogenic medium than in growth medium (DMEM 20%). Stimulated cells spread throughout the biomaterials in high percentage, showing a good morphology at both times as well as a wide distribution of ECM. They showed high percentages of positivity for safranin O, Toluidine Blue, aggrecan and type II collagen. Degradation of biomaterials was gradual, as fibers were replaced with ECM. Molecular analysis indicated the expression of cartilage-characteristic genes, such as Col II and Sox9. Scanning and transmission electron microscopy confirmed cell presence and ECM synthesis after 16 and 30 days of culture. Cells showed a high number of distended rough endoplasmic reticulum cisternae, electrodense vesicles and mitochondria. Finally, culture supernatants analysis showed the release of collagen in most of the time periods studied, confirming their differentiation and cartilage ECM characteristic compounds.

Conclusion: Our data demonstrated that type I collagen and HS scaffolds were optimal for BM-MSCs growth and differentiation towards chondrocytes-like cells after both 16 and 30 days in chondrogenic medium. Our scaffolds favour phenotypic maintenance of the differentiated cells and synthesis of cartilage-like tissue. Acknowledgements: Opocrin, S.P.A; CIBER BBN CB06-01-0040; SAI-UDC; P. Esbrit (Fundación Jiménez Díaz).

Figure 1. Analysis of BM-MSCs cultured over type I collagen and HS scaffolds on chondrogenic medium: Histochemical and immunohistochemical staining after 16 days in culture (A-D); transmission electron microscopy analysis after 16 days (E, F) and 30 days (G, H) in culture; scanning electron microscopy  after 30 days in culture (I-L). White arrows: cells. Black arrows: ECM.


Disclosure:

A. H. Martinez-Sanchez,
None;

C. Sanjurjo-Rodriguez,
None;

S. Diaz-Prado,
None;

E. Muiños,
None;

I. M. Fuentes,
None;

F. J. De Toro,
None;

J. Bujan,
None;

F. J. Blanco,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tissue-engineering-for-articular-cartilage-repair-culturing-bone-marrow-mesenchymal-stem-cells-on-collagen-and-heparan-sulphate-scaffolds/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology